Private company

ICAD INC

American surgical and medical instruments and apparatus company. Summary from the record

Last updated Oct 19, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersNashua, New Hampshire1
  • Incorporated inDE2
  • Business address98 Spit Brook Road, Suite 100, Nashua, Nh 030622
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Powered by advances in artificial intelligence ("AI"), and built on one of the largest, most diverse US and global data sets, the ProFound Breast Health Suite uniquely offers solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. The ProFound Detection solution scores cases and suspicious lesions, helping radiologists identify and focus on areas of most concern and highest suspicion of cancer. The ProFound Suite’s Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image. The ProFound AI Risk solution provides a near-term probability for developing breast cancer in the next one or two years, making it more relevant than generalized lifetime risk scores.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

84.8%Gross margin4
-32.0%Operating margin4
-28.6%Net margin4
13.2%Revenue growth, 20244
-19.6%Return on equity4
-$4.1MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue15¢$3.0M
  • Research and development34¢$6.6M
  • Other costs51¢$9.9M
  • Income tax0¢$98.0K

Out of $19.6M in revenue.4 The company lost money this year.

Financial statements

Revenue56784$19.6M in 2024−22% since 2018
0$10.0M$20.0M$30.0M$40.0M2018: $25.1M$25.1M20182019: $31.3M$31.3M2019+25%2020: $29.7M$29.7M2020−5%2021: $33.6M$33.6M2021+13%2022: $19.8M$19.8M2022−41%2023: $17.3M$17.3M2023−13%2024: $19.6M$19.6M2024+13%
Gross profit56784$16.6M in 2024−14% since 2018
0$10.0M$20.0M$30.0M2018: $19.4M$19.4M20182019: $24.2M$24.2M2019+25%2020: $21.4M$21.4M2020−12%2021: $24.2M$24.2M2021+14%2022: $16.8M$16.8M2022−31%2023: $14.8M$14.8M2023−12%2024: $16.6M$16.6M2024+13%
Operating income56784-$6.3M in 2024−23% since 2018
-$15.0M-$10.0M-$5.0M02018: -$8.1M-$8.1M20182019: -$6.4M-$6.4M2019−21%2020: -$9.4M-$9.4M2020+47%2021: -$10.7M-$10.7M2021+14%2022: -$10.2M-$10.2M2022−5%2023: -$7.7M-$7.7M2023−25%2024: -$6.3M-$6.3M2024−18%
Net income56784-$5.6M in 2024−38% since 2018
-$20.0M-$15.0M-$10.0M-$5.0M02018: -$9.0M-$9.0M20182019: -$13.6M-$13.6M2019+50%2020: -$17.6M-$17.6M2020+30%2021: -$11.2M-$11.2M2021−36%2022: -$13.7M-$13.7M2022+21%2023: -$4.8M-$4.8M2023−65%2024: -$5.6M-$5.6M2024+16%
Fiscal year2018201920202021202220232024
Revenue$25.1M5$31.3M6$29.7M7$33.6M7$19.8M8$17.3M4$19.6M4
Cost of revenue$6.2M5$7.1M6$8.3M7$9.4M7$3.0M8$2.5M4$3.0M4
Gross profit$19.4M5$24.2M6$21.4M7$24.2M7$16.8M8$14.8M4$16.6M4
Research and development$9.4M5$9.3M6$8.1M7$9.2M7$5.5M8$5.2M4$6.6M4
Operating expenses$35.0M7$27.0M8$22.5M4$22.9M4
Operating income-$8.1M5-$6.4M6-$9.4M7-$10.7M7-$10.2M8-$7.7M4-$6.3M4
Interest$504.0K5$784.0K6$476.0K7$141.0K7$10.0K8$16.0K8
Income before tax-$11.2M7-$10.0M8-$7.0M4-$5.5M4
Income tax$42.0K5$43.0K6$38.0K7$1.0K7-$116.0K8$20.0K4$98.0K4
Net income-$9.0M5-$13.6M6-$17.6M7-$11.2M7-$13.7M8-$4.8M4-$5.6M4
Earnings per share-$0.545-$0.746-$0.807-$0.457-$0.548-$0.194-$0.214
Earnings per share (diluted)-$0.545-$0.746-$0.807-$0.457-$0.547
Shares (weighted, basic)24.8M shares725.2M shares825.6M shares426.4M shares4
Shares (weighted, diluted)24.8M shares725.2M shares825.6M shares426.4M shares4

Compare ICAD INC with another company

Leadership

Who has led ICAD INC, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (27)

Former names

  • HOWTEK INCMay 8, 1995 to Jul 15, 20022

Timeline

  1. Mar 23, 2022New chief executive Stacey M. Stevens becomes CEO13
  2. May 16, 2006New chief executive Kenneth M. Ferry becomes CEO14

Filings

220 filings to the SEC since October 2021: 5 annual reports, 12 quarterly reports, 43 major events, 89 insider forms, 12 large holders, 59 other. The latest 20:

  1. Nov 10, 2025SCHEDULE 13G/A EDGAR
  2. Jul 28, 202515-12G NOTICE OF TERMINATION EDGAR
  3. Jul 21, 2025EFFECT EDGAR
  4. Jul 21, 2025EFFECT EDGAR
  5. Jul 21, 2025EFFECT EDGAR
  6. Jul 21, 2025EFFECT EDGAR
  7. Jul 21, 2025EFFECT EDGAR
  8. Jul 21, 2025EFFECT EDGAR
  9. Jul 21, 2025EFFECT EDGAR
  10. Jul 21, 2025EFFECT EDGAR
  11. Jul 21, 2025EFFECT EDGAR
  12. Jul 21, 2025EFFECT EDGAR
  13. Jul 17, 2025S-8 POS POST EFFECTIVE AMENDMENT TO S-8 EDGAR
  14. Jul 17, 2025S-8 POS POST EFFECTIVE AMENDMENT TO S-8 EDGAR
  15. Jul 17, 2025S-8 POS POST EFFECTIVE AMENDMENT TO S-8 EDGAR
  16. Jul 17, 2025S-8 POS POST EFFECTIVE AMENDMENT TO S-8 EDGAR
  17. Jul 17, 2025S-8 POS POST EFFECTIVE AMENDMENT TO S-8 EDGAR
  18. Jul 17, 2025S-8 POS POST EFFECTIVE AMENDMENT TO S-8 EDGAR
  19. Jul 17, 2025S-8 POS POST EFFECTIVE AMENDMENT TO S-8 EDGAR
  20. Jul 17, 2025S-8 POS POST EFFECTIVE AMENDMENT TO S-8 EDGAR

The 220 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

19 open-market trades by officers, directors and large owners since October 2021: 7 buys and 12 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 31, 2023Brown Dana RSee RemarksBuy40,000$1.30$52.0KForm 4
Sep 12, 2022Go JonathanSee RemarksSale38,960$2.74$106.7KForm 4
Mar 3, 2022Irish Timothy NorrisDirectorBuy5,500$4.63$25.5KForm 4
Feb 8, 2022SASSINE ANDYDirectorSale10,000$5.49$54.9KForm 4
Feb 7, 2022SASSINE ANDYDirectorSale10,000$5.26$52.6KForm 4
Jan 7, 2022SASSINE ANDYDirectorSale10,000$6.07$60.7KForm 4
Jan 6, 2022SASSINE ANDYDirectorSale10,000$6.20$62.0KForm 4
Jan 5, 2022Stevens Stacey MCEO and PresidentBuy17,006$6.17$104.9KForm 4
Dec 9, 2021DALTON NATHANIELDirectorBuy6,900$7.24$50.0KForm 4
Dec 8, 2021Carter Charles RossCHIEF FINANCIAL OFFICERBuy7,000$7.05$49.4KForm 4
Dec 8, 2021Wood Susan AlysonDirectorBuy1,500$7.31$11.0KForm 4
Dec 8, 2021Klein Michael SDirectorBuy13,475$7.38$99.4KForm 4
Dec 7, 2021SASSINE ANDYDirectorSale10,000$7.28$72.8KForm 4
Dec 6, 2021SASSINE ANDYDirectorSale10,000$6.71$67.1KForm 4
Nov 9, 2021SASSINE ANDYDirectorSale10,000$10.30$103.0KForm 4
Nov 8, 2021Go JonathanSee RemarksSale8,750$10.86$95.0KForm 4
Nov 8, 2021SASSINE ANDYDirectorSale10,000$10.89$108.9KForm 4
Oct 7, 2021SASSINE ANDYDirectorSale10,000$10.42$104.2KForm 4
Oct 6, 2021SASSINE ANDYDirectorSale10,000$10.56$105.6KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50